Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for comparable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
“Dr. Matsumoto is a trusted physician leader with a long record of service to the college and a clear commitment to quality, safety and patient-centered care,” ACR CEO Dana H. Smetherman, MD, said May 4.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.
Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for comparable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
